VNRX-5024 Safety and PK in Healthy Adult Volunteers

NCT04314206 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: VNRX-5024
DRUG: Placebo for VNRX-5024

Sponsor

Basilea Pharmaceutica

Collaborators

[object Object]